Track topics on Twitter Track topics that are important to you
KNOXVILLE, TN -- FOTO announced May 10 the recipient of the 2015 D. L Hart International Research Award. Daniel Deutscher, PT, PhD, was honored for outstanding research in physical therapy. Deutsc...
Hamburg (ots) - - Querverweis: Bildmaterial ist abrufbar unter http://www.presseportal.de/galerie.htx?type=obs - In einem exklusiven Foto-Shooting für das People-Magazin GALA (Ausgabe 8/15, ab morg.....
A drug that’s used to control herpes simplex virus 2 (HSV-2) could reduce levels of HIV in patients who do not have genital herpes, finds a National Institutes of Health (NIH) study.
Herpes simplex virus infections are an enormous global health problem and there is currently no viable vaccine. For nearly three decades, immunologists' efforts to develop a herpes vaccine have center...
A groundbreaking trial shows that the common herpes antiviral valacyclovir reduces levels of HIV-1 even in patients without herpes - contrary to previous studies.
TUESDAY, March 17, 2015 -- A widely used herpes drug also seems to help people with the HIV virus, even if those people don't also have herpes, a new small study found. The researchers said their find...
New World Health Organization (WHO)-led global estimates for herpes simplex virus type 2, published by the journal PLOS ONE, show that more than 400 million people worldwide were infected with the vir...
(Case Western Reserve University) Case Western Reserve researchers are part of an international team that has discovered that a common herpes drug reduces HIV-1 levels -- even when patients do not hav...
Genital herpes is an infection with herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2), and is among the most common sexually transmitted diseases.
The varicella zoster virus is the causative agent of herpes zoster and varicella. In herpes zoster, the virus dormant within dorsal root ganglia is reactivated, resulting in painful vesicular lesions ...
A clinical vaccine that protects from ocular herpes simplex virus type 1 (HSV-1) infection and disease still is lacking. In the present study, preclinical vaccine trials of nine asymptomatic (ASYMP) p...
Modified herpes simplex viruses that are unable to produce glycoprotein D may make effective vaccines.
Human immunodeficiency virus (HIV)-infected persons have higher rates of herpes zoster than HIV-uninfected individuals. We assessed whether twice daily treatment with 400 mg of oral acyclovir reduces ...